GLP-1 receptor agonists semaglutide , tirzepatide , and newer agents like retatrutide and cagrilintide have fundamentally changed how we approach obesity and metabolic disease
and its constituents and relevance to neurodegenerative diseases
Reddit posts show that a fourth 503B, Olympia Pharmaceuticals, officially exited the market in 2025
This comprehensive view means your treatment plan can be tailored to your unique biology, not just your weight or BMI
On top of that, earlier this year, there was fears around cannibalisation of injectable Wegovy customers moving over to oral Wegovy due to tighter margins around the oral pill
Infused water: Refreshing and hydrating, infused with fruits or herbs